The goal of the present study was to measure the levels of DNA adducts in human nasal mucosa cells and in total white blood cells in relation to smoking. DNA was isolated from samples of 20 healthy volunteers (six smokers and 14 non-smokers). The levels of DNA adducts were measured by 32 P-postlabelling assay. In smokers the mean DNA adduct levels were 3.3 and 17.0 adducts/10 8 nucleotides in total white blood cells and nasal mucosa cells respectively. The corresponding values in non-smokers were 2.0 and 6.8 adducts/10 8 nucleotides. The mean adduct level was significantly higher in nasal mucosa cells than in total white blood cells both in smokers and non-smokers. The mean adduct levels in smokers' nasal mucosa cells were significantly higher than those in non-smokers. Thus the nasal mucosa cells constituted a sensitive tissue for the determination of cigarette smoking induced DNA adducts. Combining the sensitivity of the 32 P-postlabelling assay with the specificity of the nasal mucosa to the airborne chemical exposures, the DNA adduct analysis from human nasal mucosa cells represents a method of choice in the assessment of exposure to airborne carcinogens.
Introduction
DNA adduct formation is thought to represent an early and critical step in the process of chemical carcinogenesis (1) (2) (3) (4) (5) and it is assumed that human populations with chronically elevated DNA adduct levels may be at an increased risk of developing cancer (6) (7) (8) . DNA adducts formed in human cells by chemical carcinogens can be used as biomarkers and/or dosimeters of carcinogen exposure (6) . Many studies have utilized white blood cells or peripheral blood lymphocytes as surrogate tissues for DNA adduct analysis, because of their accessibility on a routine basis (6) . While the use of surrogate tissues remains to be properly validated, the determination of the adduct levels in target organs would always be relevant. Inhalation represents the major route by which humans are exposed to airborne chemical carcinogens, including polycyclic aromatic hydrocarbons (PAHs*). The nasopharyngeal compartment of the respiratory system is therefore the entry port for inhaled air pollutants. Being the first site of air entry, the nasal cavity is a primary target for effects from environmental contaminants (9) . In order to protect the lower airways from airborne chemical toxicants, the cells lining the nasal passages are furnished with an effective defence system. Thus, the human nasal mucosa contains high levels of xenobioticmetabolizing enzymes, e.g. P-450 isozymes, epoxide hydrolase, glutathione transferase and DT-diaphorase (10, 11) . High levels of xenobiotic-metabolizing enzymes have also been detected in other mammalian species, such as rat, mouse, rabbit, hamster and monkey (12) (13) (14) (15) . These high levels of xenobioticmetabolizing enzymes are probably necessary to rapidly metabolize and remove the inhaled xenobiotics, however, promutagens and procarcinogens could be activated by this nasal biotransformation and interact with proteins as well as DNA, forming DNA adducts.
In an earlier study (16) , we were able to show that human nasal mucosa tissue can be obtained on a routine basis, using the nasal lavage procedure. It was also shown that the cells obtained contain sufficient amounts of DNA for adduct analysis (16) . Here we validate the system further by examining the levels of DNA adducts in human nasal mucosa cells and in the total white blood cells in relation to smoking.
Materials and methods

Subjects and sampling
Nasal mucosa cells and white blood cells were collected from 20 healthy volunteers: six smokers and 14 non-smokers, mean age 44 years, who were from our institutes and had known smoking habits. The smoking years of smokers ranged from 10 to 25. All the subjects had a normal appearing nasal mucosa, the individuals with ongoing symptoms of nasal diseases or ongoing drug treatment were excluded from this study. Nasal mucosa cells were collected from all subjects three times on each Monday morning for three consecutive weeks and analysed for DNA adducts separately. After nasal lavage procedure, 10 ml peripheral blood was drawn from each individual into heparinized tubes.
Cell and nucleus isolation
Nose mucosa cells were isolated by the nasal lavage procedure as described previously (17) . Briefly, nasal lavage was performed with 10 ml sterile isotonic saline solution (0.9%), 5 ml in each nasal cavity, using a needleless syringe while the subject gently flexed his head backward and did not breathe or swallow. The saline was held in the nasopharyngeal region by palatal pressure for 10 s, and then the nasal lavage fluid containing mucosa cells was forcibly expelled into a collection vessel. The lavage fluid from each subject (8 ml) was rapidly transferred into Falcon tubes to which 0.8 ml acetylcysteine (200 mg/ml, a mucus digestant purchased from Kabi Pharmacia) was added and incubated at room temperature for 30 min with a shaking frequency of 100 cycles/min. After this incubation, the volume of lavage fluid was adjusted to 10 ml and a 0.5-ml aliquot was taken for total cell counting (monitored in a haemocytometer). The remaining sample (9.5 ml), which was used for DNA isolation, was centrifuged at 2000 g for 10 min. The resulting cell pellets were suspended in 5 ml of a medium, composed of 1% Triton X-100 (polyethylene glycol p-iso-octylphenyl ether), 75 mM NaCl and 10 mM Tris(hydroxymethyl)amino-ethanehydrochloride acid (Tris-HCl), pH 7.4. In order to obtain the cell nucleus, the cell suspensions were shaken vigorously for 10 min at room temperature and then centrifuged at 2000 g for 10 min. The nuclear pellet was resuspended in 200 µl buffer containing 75 mM NaCl and 10 mM Tris-HCl (pH 7.4) and stored at -20°C until isolation of DNA.
Blood cells were collected by centrifugation. White blood cells were isolated by lysing the red blood cells in a buffer composed of 0.1% Triton X-100, 0.15 M NaCl, 10 mM Tris-HCl (pH 7.4) followed by centrifugation at 1000 g for 5 min. In order to obtain the nuclear fraction, white blood cells were suspended in 5 ml of a medium, containing 0.5% Triton X-100, 75 mM NaCl and 10 mM Tris-HCl (pH 7.4), shaken vigorously for 10 min at room temperature and then centrifuged at 2000 g for 10 min. The nuclear pellet was resuspended in 200 µl buffer containing 75 mM NaCl and 10 mM TrisHCl (pH 7.4) and stored at -20°C until isolation of DNA.
Distribution of cells from the human nasal mucosa
Cells from one nasal lavage were treated with acetylcysteine as described above, centrifuged at 1000 g for 10 min and resuspended in 0.5 ml of phosphate buffered saline (PBS) solution. Two slides for differential cell counts were prepared by cytospin centrifugation (650 r.p.m. for 7 min). The slides were stained according to the May-Grünwald-Giemsa method and 400 cells were counted, damaged cells were excluded. The percentages of epithelial, neutrophil granulocytes, eosinophils, lymphocytes and monocytes were calculated as a fraction of total cells. Purification of DNA and 32 P-postlabelling analysis of adducts DNA was isolated from the nuclei of the nasal mucosa and white blood cells using a standard procedure involving enzymatic digestion of RNA and protein by treatment with pancreatic ribonuclease and proteinase K followed by extraction with phenol and chloroform:isoamyl alcohol (24:1), as described before (18) . Isolated DNA was quantified spectrophotometerically by measuring absorbance at 260 nm and assuming 20 OD/mg DNA. The 260/280 ratios for DNA samples ranged from 1.7 to 1.8.
DNA (1 µg) was digested into normal deoxynucleosides and adducts by the nuclease P1-mediated procedure (19). Digested DNA was labelled with 7 µCi of [γ-32 P]ATP (3000 Ci/mmol), and the adducts were analysed by multidirectional TLC, using polyethyleneimine plates (PEI-TLC), as described earlier (20, 21) . The adducts were detected by autoradiography and the adduct levels were determined by cutting the area of the TLC plates corresponding to adduct spots on autoradiographs and counting in a Cerenkov counter.
Results
A typical microscope picture of nasal lavage fluid with two different cell types of nasal mucosa cells is shown in Figure  1 . These cells are epithelial cells (large cells in the middle of the photograph) and neutrophil granulocytes.
As shown in Table I , 5ϫ10 5 cells were obtained from each nasal lavage (range between 2ϫ10 5 -2ϫ10 6 cells). The yield of DNA was 1.6-13.5 µg. The analyses were performed on 20 volunteers, aged from 25 to 55 years. All the subjects had a normal appearing nasal mucosa and did not report cold or flu symptoms in the previous 2 weeks. The individual variability of the cellular distribution in the nasal lavage fluid was high. Thus, epithelial cells and neutrophil granulocytes (consisting of the majority of the cells in the nasal lavage fluid) varied between the individuals from 20 to 100% and from 10 to 80% respectively (Table I ). The intra-individual variability (nasal lavages collected at different times from the same individual) was also high (data not shown). There was no systematic difference in the distribution of cell types between smokers and non-smokers. The 32 P-postlabelling analysis was performed three times for three separate lavages of the same individual and the mean DNA adduct levels, from nasal mucosa cells and total white blood cells, in smokers and non-smokers are presented in Table II . The results show that the DNA adduct levels in the nasal mucosa cells were significantly higher (P Ͻ 0.001) than those in the white blood cells, both in smokers and nonsmokers. Thus, the mean levels in smokers' nasal mucosa cells and white blood cells were 17.0 and 3.3 adducts/10 8 nucleotides and in non-smokers' were 6.8 and 2.0 adducts/10 8 nucleotides respectively. The mean DNA adduct levels in smokers' nasal mucosa cells (17.0 Ϯ 4.5 adducts/10 8 nucleotides) were also significantly higher (P Ͻ0.001) than those in non-smokers' nasal mucosa cells (6.8 Ϯ 2.9 adducts/10 8 nucleotides). In white blood cells, the difference between smokers (3.3 Ϯ 1.7 adducts/10 8 nucleotides) and non-smokers (2.0 Ϯ 1.0 adducts/10 8 nucleotides) was of borderline significance (P ϭ 0.051). In addition, the adduct level ratio of smokers/non-smokers was higher for the nasal mucosa cells than that of white blood cells (2.5 for the nasal mucosa cells while the corresponding ratio for the white blood cells was 1.6). There was no linear correlation between nasal mucosa cell and white blood cell adducts (r ϭ 0.31, P Ͼ 0.05).
Details of smoking history are also shown in Table II . We found no correlation in nasal mucosa cells or in white blood cells between the adduct levels and the daily consumption of cigarettes (r ϭ 0.07; r ϭ -0.14)
Autoradiograms of PEI-TLC maps showing the DNA adduct patterns from nasal mucosa cells of one smoker (A) and one non-smoker (B) are presented in Figure 2 . The adduct spots between smokers and non-smokers differed mainly among the minor adducts. White blood cells lacked the large prominent spot and had many spots of approximately even intensity (data not shown).
Discussion
A major difficulty in the assessment of human exposure to carcinogens is the inaccessibility of target tissues for DNA adduct analysis (6) . According to Beach and Gupta (6), a screening device for biomonitoring of exposure should have the following properties: (i) be sensitive enough to detect the interaction of chemicals with DNA at low (environmental) levels;
DNA adducts from smokers and non-smokers (ii) detect adducts from human samples accessible on a routine basis which provide little DNA; (iii) be quantitatively related to exposure; (iv) be applicable to detection of adducts produced by complex mixtures of chemicals including unknowns; and (v) be able to resolve, quantitate and identify adducts.
The experimental design used in the present study was to investigate if the cells obtained from the human nasal mucosa, by nasal lavage procedure fulfilled the necessary demands presented by Beach and Gupta and, therefore, can be used as a suitable human tissue for DNA adduct analysis.
The results presented here demonstrate that 5ϫ10 5 (range 2ϫ10 5 -2ϫ10 6 ) cells can be obtained from each nasal lavage from which 1.6-13.5 µg DNA can be purified. The main cell types isolated by this procedure were epithelial cells and neutrophils, 96% of the total cell number. However, the variability of the cellular distribution in the nasal lavage fluid, both the individual and the intra-individual was very high. Because the relative rate of DNA adduct formation in epithelial cells and neutrophils, respectively, is not known at the moment, further investigations are presently being designed to investigate this problem.
As compared with the levels of DNA adducts in white blood cells the corresponding levels from the nasal mucosa cells were four times higher. This may indicate that the cell lining of the nasal passages, which constitutes the first line of defence against air pollutants, represents a suitable model system in the assessment of exposure to airborne chemicals. The use- fulness of nasal epithelial tissue for human biomonitoring studies has recently been discussed by others (22) .
The present data demonstrated the presence of DNA adducts in human nasal mucosa cells in relation to smoking. In contrast, the corresponding association in white blood cells was weak. This suggests that for human exposures to airborne DNA binding compounds in general, and cigarette smoking related adducts in particular, the nasal mucosa cells could be a more sensitive and reliable marker of exposure than the white blood cells. There was no direct relationship between nasal mucosa cell adducts and the daily consumption of cigarettes. A strong association between smoking and DNA adducts in the human nasal epithelium has been shown by Peluso et al. (22) . In addition, the formation of new DNA adducts in the nasal mucosa after exposure to cigarette smoke has been demonstrated in laboratory animals (23) .
In conclusion, we have demonstrated that human nasal mucosa cells may represent a sensitive and reliable biomarker in the assessment of exposure to airborne chemical carcinogens. These cells can be isolated on a routine basis by a nasal lavage procedure that is a simple, inexpensive and non-invasive procedure that requires no anaesthetics or special equipment and provides human tissue, which is the first target of and the first line of defence against airborne chemical exposures. Because of its simplicity, the nasal lavage procedure can even be performed in workplaces, which facilitates the sample collection. Moreover, the DNA adduct levels in the tissue exceeded those found in the total white blood cells, facilitating quantification even at low levels of exposure. It is therefore suggested that human nasal mucosa fulfils the necessary demands presented by Beach and Gupta (6) and can be used as a suitable human tissue for DNA adduct analysis.
